Steroid- and ATG-resistant rejection after double forearm transplantation responds to Campath-1H

American Journal of Transplantation

Volumn 4, Issue 8, 2004, Pages 1372-1374

  Schneeberger, Stefen ^a   Kreczy, Alfons ^a   Brandacher, Gerald ^a   Steurer, Wolfgang ^a   Margreiter, Raimund ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Campath 1H; Forearm; Resistant rejection; Transplantation

Indexed keywords

ALEMTUZUMAB; BETA1 INTEGRIN; CD20 ANTIBODY; CD20 ANTIGEN; CIDOFOVIR; COTRIMOXAZOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ADULT; ARTICLE; CASE REPORT; FOREARM; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; THERAPY RESISTANCE; TRANSPLANTATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTILYMPHOCYTE SERUM; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE; EPIDERMIS; FOREARM; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATINOCYTES; LYMPHOCYTES; MALE; NECROSIS; ORGAN TRANSPLANTATION; SKIN; SKIN TRANSPLANTATION; STEROIDS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 3543001679     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00518.x     Document Type: Article

References (7)

1. Zdichavsky M, Jones JW, Ustuner ET et al. Scoring of skin rejection in a swine composite tissue allograft model. J Surg Res 1999; 85: 1-8.
2. Kanitakis J, Jullien D, Petruzzo P et al. Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation 2003; 76: 688-693.
3. Margreiter R, Brandacher G, Ninkovic M, Steurer W, Kreczy A, Schneeberger S. A double-hand transplant can be worth the effort! Transplantation 2002; 74: 85-90.
4. Rowe PA, Fan KS, Gardiner DS et al. Long-term outcome of the use of OKT3 to treat steroid-resistant acute renal allograft rejection. Transpl Int 1994; 7: 278-283.
5. Sarwal M, Chua MS, Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125-138.
6. Kirk AD, Hale DA, Mannon RB et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003; 76: 120-129.
7. Levi DM, Tzakis AG, Kato T et al. Transplantation of the abdominal wall. Lancet 2003; 361: 2173-2176.